GC052 Fever And Purulent Sputum
Fever accompanied by purulent (pus-containing) sputum is a clinical presentation indicative of a lower respiratory tract infection, most commonly bacterial pneumonia or an acute exacerbation of chronic bronchitis.
Fever and Purulent Sputum — Comprehensive Exam-Ready Notes
This GC lecture by Dr. James C.M. Ho covers lower respiratory tract infections (LRTIs) presenting with the classic duo of fever + purulent sputum. The lecture is structured around a case of a 35-year-old male smoker developing community-acquired pneumonia (CAP) after a preceding URTI, and then broadens into the full spectrum of LRTIs, influenza, and bronchiectasis. [1]
Why this matters for exams: Pneumonia is the 2nd leading cause of death in Hong Kong (since 2012). It is a bread-and-butter topic tested across MCQ, SAQ, minicase, and OSCE formats. The examiners love testing: the pathogen table by clinical setting, CURB-65, empirical antibiotic choice, complications (especially empyema vs lung abscess), and influenza antivirals. Past papers confirm this is heavily examined. [1][3]
Learning Objectives (from slide 46): [1]
- Pneumonia: common pathogens in different settings, clinical features, diagnostic approach and investigations, empirical antibiotic treatment, complications
- Influenza: clinical features and management
- Bronchiectasis: clinical features and management
The lecture lists five categories of LRTI: acute bronchitis, acute exacerbation of chronic bronchitis, bronchiectasis, pneumonia, and lung abscess. [1]
High Yield — LRTI Categories
Know these five categories cold. An exam question may present a patient with fever and purulent sputum and ask you to differentiate between them. The distinguishing features are the clinical context, CXR findings, and chronicity.
| LRTI | Key Distinguishing Features |
|---|---|
| Acute bronchitis | Self-limiting, viral, no consolidation on CXR, clear chest or scattered rhonchi |
| Acute exacerbation of chronic bronchitis | Background COPD/chronic bronchitis, increased sputum volume/purulence/dyspnoea |
| Bronchiectasis | Chronic copious sputum, clubbing, HRCT shows dilated bronchi |
| Pneumonia | Consolidation on CXR + systemic features (fever, rigors) |
| Lung abscess | Air-fluid level on CXR/CT, prolonged fever, foul sputum |
II. The Case Scenario — Walk-Through
The lecture builds around this case. Let's dissect it systematically because exam minicases follow the same structure.
- M/35, chronic smoker, good past health
- URTI symptoms (sore throat, running nose) 10 days ago ← the preceding viral illness
- Increasing cough and greenish sputum over past 5 days
- Progressive SOB with right pleuritic chest pain for 3 days
- High swinging fever with chills and rigor for 3 days
- Seen by GP → oral antibiotics + paracetamol → worsening → A&E
- Respiratory distress, mentally alert
- Chest: dullness, bronchial breath sound, and coarse inspiratory crackles over right lower chest
- BP 90/50 mmHg (hypotension → septic shock territory)
- SpO₂ 92% on room air (hypoxaemia)
Why this is CAP and not something else:
- Onset in the community (not hospitalised)
- Preceded by URTI → secondary bacterial infection is classic
- Consolidation signs (dullness + bronchial breath sounds + crackles) = lobar consolidation
- Systemic toxicity (high swinging fever, chills, rigor)
Why is he sick?
- Hypotension (BP 90/50) suggests sepsis/septic shock
- Hypoxaemia (SpO₂ 92%) suggests significant parenchymal involvement
- These features push him into the "severe CAP" category
III. Pneumonia — Core Concepts
Inflammation of lung parenchyma, commonly due to infective agents (bacteria, viruses or fungi). [1]
This is important: pneumonia = parenchymal inflammation. Bronchitis = airway inflammation. That's why you see consolidation on CXR in pneumonia but not in bronchitis.
| Classification Axis | Types |
|---|---|
| Anatomical | Lobar pneumonia, multi-lobar, bronchopneumonia |
| Aetiological | Bacterial, viral, fungal |
| Clinical | CAP, HAP, VAP, aspiration |
Anatomical Classification — What's the Difference?
- Lobar pneumonia: consolidation filling an entire lobe. Classic for S. pneumoniae. CXR shows dense homogeneous opacification with air bronchograms.
- Bronchopneumonia: patchy consolidation centered around airways, often bilateral and basal. Classic in elderly, debilitated patients. CXR shows patchy infiltrates.
- Multi-lobar: involvement of ≥2 lobes. A poor prognostic factor.
Pneumonia: 2nd leading cause of death in HK since 2012; 17% of deaths in 2022; 42,403 hospital admissions (2.34% of total) in 2021.
This is HK-specific data the examiners love. Pneumonia overtook cancer as the 2nd leading cause of death in 2012 (it was 3rd from 2003-2011).
This is one of the most exam-tested slides in the entire lecture. You must know this table.
Causative pathogens depend on clinical settings and host factors. [1]
| Pathogen | Gram | CAP | HAP | Aspiration |
|---|---|---|---|---|
| Streptococcus pneumoniae | Gram + | ++ | + | - |
| Haemophilus influenzae | Gram - (lecture labels it Gram + but it's actually Gram -) | + | + | - |
| Mycoplasma pneumoniae | Atypical | + | - | - |
| Chlamydophila pneumoniae | Atypical | + | - | - |
| Legionella pneumophila | Atypical | + | - | - |
| Klebsiella pneumoniae, Pseudomonas aeruginosa | Gram - | +/- | ++ | + |
| MRSA | Gram + | +/- | ++ | - |
| Bacteroides spp (anaerobes) | Anaerobe | - | + | ++ |
High Yield — Pathogen Patterns
Memory framework:
- CAP = S. pneumoniae is KING (must cover in ALL cases) + atypicals (Mycoplasma, Chlamydophila, Legionella)
- HAP = Resistant organisms: Gram-negatives (Klebsiella, Pseudomonas, ESBL-producers) + MRSA
- Aspiration = Anaerobes (Bacteroides) from oropharyngeal flora ± Gram-negatives
Common Exam Trap
Don't forget Mycobacterium tuberculosis — especially in HK or endemic areas. The lecture specifically mentions TB as a causative pathogen. If a question shows a patient with "fever, weight loss, night sweats, haemoptysis" and sputum culture grows nothing on standard media, think TB. TB accounts for ~12.5% of CAP in HK. [1][2]
Sputum colour clues (from supporting material) [2][4]:
- Rusty sputum → S. pneumoniae (classic for lobar pneumonia)
- Currant-jelly sputum → Klebsiella pneumoniae
- Foul-smelling, dark sputum → anaerobic lung abscess
- Pink frothy sputum → pulmonary oedema (not infection!)
V. Community-Acquired Pneumonia — Clinical Features
Cough, sputum, haemoptysis, dyspnoea, pleuritic chest pain; fever, chills, rigor; confusion, constitutional or systemic symptoms.
Why each symptom occurs:
- Cough + sputum: inflammatory exudate in alveoli stimulates cough reflex; purulent sputum = neutrophilic response to bacterial infection
- Haemoptysis: necrosis of alveolar tissue or inflamed bronchial mucosa
- Pleuritic chest pain: inflammation reaching the visceral/parietal pleura → sharp, stabbing pain worse with inspiration
- Fever/chills/rigor: systemic inflammatory response; rigor (uncontrollable shaking) suggests bacteraemia
- Confusion: especially in elderly; marker of severe disease (the "C" in CURB-65)
Chest: percussion dullness, bronchial breath sound, coarse crackles, increased vocal resonance. Vital signs: BP, SpO₂; mental state.
Why these signs occur — from first principles:
- Percussion dullness: consolidated (solid) lung transmits percussion energy poorly → dull note (vs resonant normal air-filled lung)
- Bronchial breath sounds: normally heard only over trachea. When lung is consolidated, it conducts sound from central airways to the chest wall without filtering → harsh, hollow quality heard peripherally
- Coarse crackles: secretions in airways "pop" open during inspiration
- Increased vocal resonance (including whispering pectoriloquy and aegophony): consolidated lung transmits voice sounds more efficiently than air-filled lung
Travel, Occupation, Contact, Clustering
This is crucial for identifying atypical pathogens and notifiable diseases:
- Travel: Legionella (contaminated water systems, hotels), TB (endemic areas), MERS (Middle East)
- Occupation: healthcare workers (TB, influenza), farmers (Q fever, melioidosis)
- Contact: household contacts with similar illness → viral, TB
- Clustering: outbreak → influenza, COVID-19, Legionella
Usually refers to M. pneumoniae, C. pneumoniae, L. pneumophila. Syndrome of pneumonitis, fever, and a relatively normal WBC, without identifiable bacterial pathogens. Prominent systemic complaints.
Why "atypical"?
- These organisms don't grow on standard blood agar/chocolate agar (hence "without identifiable bacterial pathogens")
- They cause interstitial rather than alveolar inflammation → less sputum production
- Systemic symptoms (headache, myalgia, malaise) are disproportionately prominent vs respiratory symptoms
- WBC is typically normal (unlike typical bacterial pneumonia where WBC is elevated)
- CXR often shows patchy/interstitial infiltrates rather than dense lobar consolidation
Past Paper Alert
2021 MCQ Q89: A 36-year-old lady with CAP, sputum culture grew only oral commensals, treated with augmentin + doxycycline with rapid improvement. Most likely causative organism? Answer: D. Mycoplasma pneumoniae — because no growth on standard culture + response to doxycycline (which covers atypicals). [3]
VI. Clinical Approach to CAP
The lecture outlines four steps: (1) Establish diagnosis, (2) Identify causative pathogens, (3) Assess clinical severity, (4) Empirical antibiotic treatment. [1]
Compatible respiratory symptoms and signs + Chest X-ray: consolidations in lobar pneumonia; patchy infiltrates in bronchopneumonia.
CXR is the gold standard for diagnosis. You need BOTH clinical features AND radiographic evidence. A patient with cough and fever but a clear CXR does NOT have pneumonia (they have acute bronchitis or URTI).
Further investigations:
- Complete blood counts (total WBC and differential counts)
- Electrolytes, liver and renal function tests
- Arterial blood gases
- Atypical pneumonia serology
- Nasopharyngeal aspirate if influenza or atypical pneumonia suspected
- Urinary antigen test for Legionella and pneumococcus
- Sputum and blood cultures
Why each investigation matters:
| Investigation | Purpose | Key Points |
|---|---|---|
| CBC with differential | Assess WBC response; leukocytosis suggests bacterial; normal/low WBC in atypical or immunocompromised | Very high WBC ( > 11) or very low WBC ( < 4) = poor prognosis |
| Electrolytes, LFT, RFT | Urea > 7 is CURB-65 criterion; detect SIADH (hypoNa); assess organ function | Urea > 8 = poor prognostic factor |
| ABG | Quantify hypoxaemia; assess for respiratory failure | PaO₂ < 8 kPa (60 mmHg) = poor prognosis |
| Atypical serology | Retrospective diagnosis of Mycoplasma, Chlamydophila, Legionella | 4-fold rise in paired sera (acute + convalescent) |
| NPA | Rapid antigen test or PCR for influenza, respiratory viruses | Important for infection control + antiviral decision |
| Urinary antigen | Detect Legionella serogroup 1 and S. pneumoniae | Remains positive even after antibiotics started |
| Sputum culture | Identify pathogen and sensitivity | Only valid if good quality sample (many PMNs, few epithelial cells) |
| Blood cultures | Detect bacteraemia | Positive in ~10-20% of hospitalised CAP; bacteraemia = poor prognosis |
Past Paper Alert — Urinary Antigen
2023 MCQ Q40: 65-year-old woman with CKD, fever, cough, yellowish sputum, RLL consolidation, normal WBC, no growth on sputum culture. Which investigation helps confirm aetiology? Answer: D. Urinary pneumococcal antigen — because normal WBC + no sputum growth could be due to prior antibiotics or atypical presentation; urinary antigen remains positive. [3]
Microbiological diagnosis is retrospective. Initial management is based on clinical setting and host factors.
This is a critical teaching point: you almost never know the pathogen when you start treatment. You must use clinical context to make your best guess and start empirical therapy.
Need to cover Streptococcus pneumoniae in ALL cases of CAP. Need to cover Legionella pneumophila in SEVERE cases of CAP.
Why cover Legionella in severe CAP?
- Legionella causes severe disease with multi-organ involvement
- It is an intracellular pathogen → beta-lactams alone won't work
- Requires macrolide (azithromycin/clarithromycin) or fluoroquinolone for coverage
- This is why severe CAP regimens always include a macrolide
CURB-65:
- C — Confusion
- U — Urea > 7 mmol/L
- R — Respiratory rate > 30/min
- B — Blood pressure (SBP < 90 mmHg OR DBP < 60 mmHg)
- 65 — Age > 65 ≥2 factors present → hospital admission
| CURB-65 Score | Mortality | Disposition |
|---|---|---|
| 0-1 | ~1.5% | Outpatient |
| 2 | ~9.2% | Hospital admission (short-stay/general ward) |
| ≥3 | ~22% | Assess for ICU admission |
Apply to the case: The 35-year-old man has: BP 90/50 (✓B), SpO₂ 92% (implies RR likely elevated), no confusion mentioned. Score ≥2 → hospital admission. Given hypotension → consider ICU.
Poor prognostic factors: old age, hypoxaemia (PaO₂ < 8 kPa), high ( > 11 × 10⁹/L) or low WBC ( < 4 × 10⁹/L), high urea ( > 8 mmol/L), multilobar involvement, bacteraemia. [1]
High Yield — CURB-65 vs Poor Prognostic Factors
CURB-65 is a quick bedside scoring tool. The "poor prognostic factors" list is broader and includes lab values (WBC extremes, bacteraemia) and imaging (multilobar). Know both for exams — CURB-65 for disposition decisions, prognostic factors for SAQ answers asking "what features suggest poor prognosis."
Need to administer appropriate antibiotics timely (preferably within 6-8 hours).
Empirical regimen: Penicillin with beta-lactamase inhibitor +/- macrolide or tetracycline. E.g. Amoxicillin-clavulanate (Augmentin) +/- clarithromycin or azithromycin or doxycycline. Duration ~7-10 days.
Why this combination?
- Amoxicillin-clavulanate (Augmentin): covers S. pneumoniae, H. influenzae (including beta-lactamase producing strains), and many Gram-negatives. The clavulanate inhibits beta-lactamase enzymes that would otherwise destroy amoxicillin.
- Macrolide (clarithromycin/azithromycin) or doxycycline: covers atypical pathogens (Mycoplasma, Chlamydophila, Legionella) which are intracellular and not covered by beta-lactams. Added especially in severe CAP to cover Legionella.
Risk factors for multi-drug resistant pathogens: recent/frequent antibiotic use, recent/frequent hospitalization, nursing home residents, immunosuppressive disease or therapy. [1]
Why this matters: If MDR risk factors are present, you may need to escalate beyond standard Augmentin to broader-spectrum agents (e.g., respiratory fluoroquinolone or broader beta-lactam).
O₂ or mechanical ventilation for respiratory failure; chest physiotherapy; fluid rehydration; treat underlying COPD with bronchodilators; control cardiac arrhythmias (e.g. AF).
Why AF in pneumonia?
- Infection → systemic inflammation → autonomic imbalance + hypoxia + fever → triggers atrial fibrillation, especially in elderly patients
- AF with rapid ventricular response can worsen haemodynamic status
- Usually reverts with treatment of the underlying infection
VII. Hospital-Acquired Pneumonia (HAP)
Pneumonia occurring > 48 hours after hospitalization.
This time threshold is critical — it distinguishes HAP from CAP that was incubating at the time of admission.
Mostly related to aspiration of oropharyngeal secretions colonized by hospital-acquired organisms.
Why hospitals are different: The oropharynx becomes colonized with Gram-negative bacilli and resistant organisms within 48 hours of hospital admission (due to altered mucosal defences, exposure to antibiotics, supine positioning, and invasive devices).
General debility and old age, cigarette smoking, COPD, aspiration, post-GA, H₂ blockers or antacids, nasogastric tube, mechanical ventilation (VAP).
Why H₂ blockers/antacids? They raise gastric pH → allow bacterial colonization of the stomach → retrograde colonization of the oropharynx → aspiration. This is a classic exam question.
Cover Strep. pneumoniae, resistant Gram +ve (may include MRSA), Gram -ve (Klebsiella, Pseudomonas, ESBL-producing organisms), anaerobes. Extended spectrum penicillin or third-generation cephalosporin or carbapenem. E.g. piperacillin-tazobactam (Tazocin) or meropenem.
Why broader spectrum than CAP?
- HAP pathogens are more resistant (hospital environment selects for resistance)
- Must cover Pseudomonas (which is inherently resistant to many antibiotics)
- ESBL-producers are not covered by standard cephalosporins → need carbapenems
- May add vancomycin if MRSA is suspected
| Setting | Empirical Antibiotics | Key Pathogens |
|---|---|---|
| CAP (mild-moderate) | Augmentin ± macrolide/doxycycline | S. pneumoniae, H. influenzae, atypicals |
| CAP (severe) | Augmentin + macrolide (must cover Legionella) | As above + Legionella |
| HAP | Tazocin or meropenem ± vancomycin | MRSA, Pseudomonas, Klebsiella, ESBL |
| Aspiration | Augmentin (cover anaerobes) | Bacteroides, mixed oropharyngeal flora |
VIII. Aspiration Pneumonia
Altered consciousness, alcoholism, vomiting, dysphagia and oesophageal diseases, neurological disorders (bulbar palsy), nasogastric tube feeding, severe dental or URTI, terminal illness, drowning.
Common thread: All these conditions impair airway protective reflexes (gag, cough, swallowing coordination) → aspiration of oropharyngeal or gastric contents into the lower respiratory tract.
Usually affects dependent parts of lungs:
- Lower lobes (especially on the right)
- Posterior segments of upper lobes (in those mostly recumbent)
Why right lower lobe? The right main bronchus is wider, shorter, and more vertical than the left → aspirated material preferentially flows to the right lung.
Videofluoroscopic swallowing test (VFSS) — to confirm swallowing dysfunction and guide feeding strategy.
Antibiotics covering oropharyngeal flora especially anaerobes → Penicillins → e.g. amoxicillin-clavulanate (Augmentin). Treatment of underlying conditions. Prevention of further aspiration → non-oral feeding (e.g. via percutaneous endoscopic gastrostomy [PEG]).
IX. Complications of Pneumonia
This is a favourite exam topic, especially distinguishing lung abscess from empyema.
- Severe pneumonia → widespread alveolar consolidation → V/Q mismatch → hypoxaemia
- May progress to ARDS if overwhelming inflammation
- Bacteraemia → sepsis → septic shock → organ dysfunction (renal, hepatic, coagulopathy)
Air-fluid level, cavity. Could be polymicrobial. Needs prolonged (4-6 weeks) antibiotics. No need for percutaneous drainage in most cases.
Why 4-6 weeks? The abscess cavity has poor blood supply (surrounded by necrotic tissue) → antibiotics penetrate poorly → need prolonged course for sterilization.
Why no drainage usually? Most lung abscesses drain spontaneously via the bronchial tree (the patient coughs up the pus). Percutaneous drainage risks bronchopleural fistula and empyema. Surgery/drainage reserved for failure to respond.
- Reactive pleural effusion adjacent to pneumonia
- Initially sterile (simple parapneumonic effusion) → may become infected → complicated effusion → empyema
Pus in pleural cavity (gross appearance, Gram's staining or culture). Needs prolonged (4-6 weeks) antibiotics. Pleural drainage (e.g. intercostal tube) is needed.
Key difference from lung abscess: Empyema = pus in the pleural space (needs drainage). Lung abscess = pus in the lung parenchyma (usually drains via bronchi, no external drainage needed).
Past Paper Alert — Empyema
2016 SAQ Q3: "Name five features of pleural fluid that would suggest empyema thoracis." Answer should include: (1) Frankly purulent/pus-like appearance, (2) Positive Gram stain, (3) Positive culture, (4) pH < 7.2, (5) Glucose < 2.2 mmol/L (or < 40 mg/dL), (6) LDH > 1000 IU/L. [3]
2020 MCQ Q45: 50-year-old man with persistent fever despite oral Augmentin for 5 days, RLZ stony dullness with bronchial breath sounds and crackles above. Most likely diagnosis: B. Empyema thoracis — the stony dullness indicates fluid (empyema), with overlying consolidation above the fluid level. [3]
Electrolyte abnormalities e.g. hypoNa due to SIADH; acute myocardial infarction; cardiac arrhythmia (AF).
Why SIADH in pneumonia? Inflamed lung tissue can produce ADH ectopically → inappropriate water retention → dilutional hyponatraemia. This is especially common with Legionella pneumonia.
Causes: diffuse bronchopulmonary diseases (e.g. bronchiectasis), recurrent aspiration, immunocompromised (HIV, malignancies), bronchial obstruction (tumour, foreign body).
Investigations: CT thorax, bronchoscopy, sputum AFB and cytology, blood for immunodeficiency.
Why investigate recurrent pneumonia aggressively? A single episode of CAP in a young, healthy person doesn't need extensive workup beyond standard. But recurrent pneumonia (≥2 episodes in 1 year or ≥3 ever, with radiographic clearing between episodes) demands investigation for an underlying structural, immunological, or malignant cause.
XI. Influenza
Influenza A and B. Immunogenic surface antigens: Haemagglutinin (H) and Neuraminidase (N).
Why H and N matter:
- Haemagglutinin (H): binds sialic acid on host respiratory epithelial cells → mediates viral entry
- Neuraminidase (N): cleaves sialic acid → releases progeny virus from infected cells → allows spread
Antigenic shift: major changes in antigens (e.g. H3N2 to H1N1). Antigenic drift: minor changes in antigens. Worldwide pandemics due to antigenic shift resulting in a new highly pathogenic virus, without specific natural immunity. [1]
| Concept | Mechanism | Clinical Consequence |
|---|---|---|
| Antigenic drift | Point mutations in H or N genes | Seasonal epidemics; basis for annual vaccine updates |
| Antigenic shift | Reassortment of genome segments (e.g. between human + avian strains) | Pandemics; population has no pre-existing immunity |
Why does shift cause pandemics but drift doesn't? Drift causes small changes → most people have partial immunity from prior exposure → seasonal outbreaks. Shift creates an entirely new H or N subtype → nobody has immunity → explosive global spread.
In Hong Kong, influenza is more common from January to March and from July to August.
This is HK-specific and testable — two peaks per year, unlike temperate countries with one winter peak.
URTI symptoms: running nose, sore throat, cough and sputum. Fever, myalgia, arthralgia. Lower respiratory tract or systemic involvement.
Distinguishing influenza from common cold: Influenza has prominent systemic symptoms (high fever, myalgia, prostration) that are disproportionate to respiratory symptoms. Common colds have predominant nasal symptoms with mild or no systemic upset.
Rapid antigen test on NPA, RT-PCR, viral cultures, serology.
- Rapid antigen test: results in 15-30 minutes; moderate sensitivity (~60-70%), high specificity
- RT-PCR: gold standard; high sensitivity and specificity; results in hours
- Viral culture: takes days; mainly for epidemiological surveillance
- Serology: retrospective (paired sera); not useful for acute management
Personal hygiene, symptomatic treatment, specific antivirals.
F. Antivirals
Interfere with viral uncoating inside cell. Effective only against influenza A. Severe toxic effects, mainly neurological. Rapid emergence of drug resistance. Not useful in treating avian flu.
Why are these no longer first-line? Widespread resistance (especially H3N2 and H1N1pdm09 strains) + significant neurological side effects (insomnia, confusion, hallucinations) → largely abandoned in clinical practice.
Interfere with release of progeny influenza virus from infected host cells, thus stopping spread of infection in respiratory tract. Effective against both influenza A and B. Active when given as early as possible (within 48 hours). E.g. oseltamivir (Tamiflu), zanamivir (Relenza).
Why within 48 hours? NIs work by preventing viral spread from already-infected cells. After 48 hours, viral replication has peaked and the immune response is already the primary driver of disease → antivirals add little benefit.
| Feature | Amantadine/Rimantadine | Neuraminidase Inhibitors |
|---|---|---|
| Mechanism | Block M2 ion channel → prevent viral uncoating | Block neuraminidase → prevent viral release |
| Coverage | Influenza A only | Influenza A and B |
| Administration | Oral | Oseltamivir: oral; Zanamivir: inhaled |
| Timing | Within 48h | Within 48h |
| Resistance | Rapid, widespread | Less common but emerging |
| Side effects | Neurological (severe) | GI upset (oseltamivir); bronchospasm (zanamivir) |
| Current role | Largely abandoned | First-line antiviral |
XII. Bronchiectasis
Pathological dilatation of bronchi. Generalized or localized. Cause: mostly idiopathic (needs to exclude other causes e.g. post-infection, TB).
Why does bronchiectasis develop? The "vicious cycle" hypothesis: infection → inflammation → structural damage to bronchial walls → impaired mucociliary clearance → mucus pooling → further infection → more damage. The end result is irreversible dilation of bronchi.
Causes to exclude:
- Post-infectious: childhood measles/pertussis/severe pneumonia, TB
- Immunodeficiency: hypogammaglobulinaemia, HIV
- Cystic fibrosis (sweat test)
- Primary ciliary dyskinesia (ciliary + sperm analysis)
- Aspiration/GORD (barium studies/pH monitoring)
- Allergic bronchopulmonary aspergillosis (ABPA)
- Autoimmune: RA, SLE
Symptoms:
Chronic sputum production and cough, infective exacerbations, haemoptysis (usually infective), weight loss, fatigue, chest pain, dyspnoea.
Signs:
Cachexia, clubbing, coarse crackles, associated COPD, respiratory failure.
Why clubbing? Chronic suppurative lung disease → likely related to circulating growth factors (VEGF, PDGF) from chronically inflamed tissue → nail bed vasodilation and connective tissue proliferation.
Progressive lung damage, lung abscesses, empyema, brain abscesses.
Why brain abscesses? Right-to-left shunting through the pulmonary circulation (from damaged lung with AV shunting or hypoxia-induced pulmonary hypertension → patent foramen ovale) allows septic emboli to bypass the pulmonary filter → seed the brain. This is a classic exam discriminator.
CXR may be normal or show tramline shadows. HRCT thorax [gold standard]. Immunoglobulins. Auto-antibodies. Barium studies or 24h oesophageal pH monitoring. Ciliary and sperm analysis. Sputum culture and AFB. Neutrophil functions. Sweat test.
| Investigation | What It's Looking For |
|---|---|
| HRCT thorax | Confirms bronchiectasis (dilated bronchi, "signet ring" sign) |
| Immunoglobulins | Hypogammaglobulinaemia (common variable immunodeficiency) |
| Auto-antibodies | Underlying autoimmune cause (RA, SLE) |
| Barium/pH study | GORD-related aspiration |
| Ciliary + sperm analysis | Primary ciliary dyskinesia (Kartagener syndrome) |
| Sweat test | Cystic fibrosis |
| Sputum AFB | Tuberculosis or NTM |
| Neutrophil function | Rare immunodeficiency |
E. Treatment [1]
Potential organisms: Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa (if long-standing). Anti-pseudomonal antibiotics: extended spectrum penicillins (piperacillin-tazobactam), 3rd gen cephalosporins (ceftazidime), carbapenems (meropenem), aminoglycosides (amikacin), fluoroquinolones (levofloxacin).
Why Pseudomonas in long-standing bronchiectasis? Chronic airway damage + mucus pooling create an environment where Pseudomonas thrives. Once colonized, it's extremely difficult to eradicate due to biofilm formation.
ICS +/- LABA (only for concomitant airflow obstruction/bronchospasm). Long-term macrolides — immunomodulating rather than antibiotic effect (e.g. azithromycin, erythromycin). Watch out for prolonged QTc. Postural drainage. Surgery for very limited disease. Lung transplantation.
Why long-term macrolides? At sub-antimicrobial doses, macrolides reduce neutrophilic inflammation, decrease mucus hypersecretion, and modulate immune responses. They reduce exacerbation frequency by ~30-50%. The QTc prolongation risk mandates baseline and follow-up ECGs.
Postural drainage: Uses gravity to drain secretions from dilated bronchi. Patient positioned so affected segments are uppermost → secretions drain into central airways → coughed out. Essential part of daily airway clearance.
XIII. Integration with Related Material
- Sputum Gram stain and culture: a good quality specimen should have > 25 PMNs and < 10 squamous epithelial cells per low-power field
- Blood cultures: always two sets (aerobic + anaerobic) from different sites before antibiotics
- MALDI-TOF mass spectrometry increasingly replacing traditional culture for rapid pathogen identification
- Fever = core temperature ≥38.0°C (oral ≥37.5°C)
- Swinging/hectic fever pattern: suggestive of abscess or empyema (wide temperature fluctuations)
- CXR for pneumonia: look for consolidation, air bronchograms, pleural effusion, cavity/air-fluid level
- CT thorax: for complications (abscess, empyema, underlying tumour) and for bronchiectasis diagnosis (HRCT)
- From respiratory DI sessions [8]: Interpreting ABG in the context of pneumonia:
- Type 1 respiratory failure: low PaO₂, normal/low PaCO₂ (pneumonia)
- Type 2 respiratory failure: low PaO₂, high PaCO₂ (severe pneumonia with exhaustion, or underlying COPD)
XIV. Likely Exam Questions
-
A 45-year-old diabetic presents with high fever, cough with currant-jelly sputum, and RUL consolidation. Most likely pathogen?
- Answer: Klebsiella pneumoniae (currant-jelly sputum + diabetic/alcoholic + upper lobe predilection)
-
A 70-year-old nursing home resident develops fever 5 days after hospital admission. Which antibiotic is most appropriate?
- Answer: Piperacillin-tazobactam (Tazocin) — HAP requires coverage of Gram-negatives including Pseudomonas
-
Which influenza antiviral is effective against both influenza A and B?
- Answer: Neuraminidase inhibitors (oseltamivir, zanamivir)
-
What is the CURB-65 threshold for hospital admission?
- Answer: Score ≥2
-
List 5 complications of pneumonia. (10 marks)
- Respiratory failure, septicaemia/multi-organ failure, lung abscess, parapneumonic effusion/empyema, SIADH with hyponatraemia, AF, acute MI
-
A patient with bronchiectasis has recurrent exacerbations despite standard treatment. Name two long-term pharmacological strategies.
- Long-term macrolides (azithromycin) for immunomodulation; inhaled anti-pseudomonal antibiotics (if colonized)
-
List 5 predisposing factors for aspiration pneumonia. (10 marks)
- Altered consciousness, alcoholism, dysphagia/oesophageal disease, bulbar palsy, nasogastric tube feeding, vomiting, severe dental infection, drowning, terminal illness
- A 61-year-old chronic smoker with previous TB presents with acute greenish sputum and haemoptysis. Name 5 physical examination findings suggesting respiratory failure.
- Tachypnoea, use of accessory muscles, cyanosis (central), tachycardia, confusion/altered consciousness, oxygen desaturation (SpO₂ < 92%), asterixis (CO₂ retention flap), inability to speak in full sentences [3]
Exam Traps to Avoid
-
Confusing HAP with CAP timing: HAP = onset > 48 hours after hospitalisation. A patient admitted yesterday with a cough has CAP, not HAP.
-
Forgetting Legionella in severe CAP: Always add a macrolide or doxycycline in severe CAP to cover Legionella. Augmentin alone is insufficient.
-
Lung abscess vs empyema management: Lung abscess = prolonged antibiotics, usually NO drainage. Empyema = prolonged antibiotics + DRAINAGE (intercostal tube).
-
Amantadine coverage: Only influenza A. NIs cover both A and B. Don't mix these up.
-
Normal WBC in pneumonia: Doesn't exclude bacterial pneumonia — it may indicate atypical pathogen OR immunosuppression OR overwhelming infection (leucopenia = poor prognosis).
-
Antigenic shift vs drift: Shift = pandemics (reassortment, new subtype). Drift = seasonal epidemics (point mutations, gradual change). The words rhyme with opposite concepts — "shift is BIG, drift is little."
-
Right lower lobe in aspiration: Aspirated material goes to the RLL because the right main bronchus is wider, shorter, and more vertical.
High Yield Summary
Pneumonia: Inflammation of lung parenchyma. Classify by setting (CAP/HAP/aspiration), anatomy (lobar/bronchopneumonia), and aetiology. CAP: cover S. pneumoniae always (Augmentin) + atypicals in severe (macrolide). HAP: cover Pseudomonas and MRSA (Tazocin/meropenem). Aspiration: cover anaerobes (Augmentin), prevent further aspiration.
CURB-65 ≥2 → admit. Poor prognostic factors: old age, hypoxaemia, extreme WBC, high urea, multilobar disease, bacteraemia.
Complications: Respiratory failure, sepsis, lung abscess (prolonged Abx, no drainage), empyema (prolonged Abx + drainage), SIADH, AF, MI.
Influenza: H and N antigens. Antigenic shift → pandemic. NIs (oseltamivir) effective against A+B within 48h. Amantadine: influenza A only, largely abandoned.
Bronchiectasis: Pathological bronchial dilatation, mostly idiopathic. HRCT diagnostic. Acute exacerbation: cover Pseudomonas (Tazocin/ceftazidime). Long-term: macrolides for immunomodulation + postural drainage. Complications include brain abscess.
Active Recall - Fever and Purulent Sputum
[1] Lecture slides: GC 052. Fever and purulent sputum.pdf (slides 1-47) [2] Senior notes: Ryan Ho Respiratory.pdf (p62, p68) [3] Past papers: 2016 Fourth Summative SAQ.pdf (Q3), 2020 Fourth Summative Assessment MCQ paper.pdf (Q45), 2021 Fourth Summative Assessment MCQ.pdf (Q89), 2023 Fourth Summative MCQ.pdf (Q40), 2023 Fourth Summative Minicase.pdf (Case 1), 2024 Fourth Summative MCQ.pdf (Q1-4, Q37) [4] Senior notes: Ryan Ho Fundamentals.pdf (p220-221) [5] Lecture slides: GC 101. Diagnosis of infections.pdf [6] Lecture slides: GC 048. Fever.pdf [7] Lecture slides: GC 016. Radiology of Common Medical and Surgical Problems.pdf; Respiratory- Introduction to Resp investigations (CXR, CT thorax and lung function tests).pdf [8] Lecture slides: DL_Data_Interpretation_20141023.pdf (p8, p18)
GC051 Fever And Confusion: Meningitis And Encephalitis; Suppurative Brain Infection
Fever accompanied by altered mental status can indicate meningitis (infection/inflammation of the meninges), encephalitis (infection/inflammation of the brain parenchyma), or suppurative brain infections such as cerebral abscess, which are life-threatening conditions requiring urgent diagnosis and treatment.
GC053 Fingers Turn White And Blue
Raynaud phenomenon is episodic vasospasm of the digital arteries causing sequential color changes of the fingers—white (ischemia), blue (cyanosis), and red (reperfusion)—typically triggered by cold exposure or emotional stress.